Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    TopAbstracts in Hypertension 12/02/2009 - (DGNews)
    Obesity Leading Risk Factor of Left Atrial Enlargement During Aging - (DGNews)
    TopAbstracts in Hypertension 11/25/2009 - (DGNews)
    Team-Based Care Involving a Pharmacist Improves Blood Pressure Control - (DGNews)
    Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study - (BMJ)

    News archive

     Recent webcasts/CME - Hypertension
    • State of the Art in Pulmonary Arterial Hypertension
    • Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment
      Treating Coronary Artery Disease in Vulnerable Adults
      Thrombotic Thrombocytopenic Purpura: The Masquerader

      Webcasts/CME archive

       Recent cases - Hypertension
        A Woman with Swollen Fingers and New-Onset Hypertension and Renal Failure
        Hypertension
        Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
        Malignant Hypertension and Acute Aortic Dissection Associated with Caffeine-Based Ephedra-Free Dietary Supplements: A Case Report
        Giant Right Coronary Artery Aneurysm: Case Report and Literature Review

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Impotent Patients on Valsartan Find Increased Interest in Sex; Use Sildenafil More Often: Presented at ASH

        By Ed Susman

        NEW YORK, NY -- May 19, 2002 -- Hypertensive patients with erectile dysfunction who are taking the angiotensin II receptor blocker valsartan find they have increased sexual desire, and that increase is documented by increased use of sildenafil pills, researchers reported.

        "We have known from past studies that patients on valsartan say they have greater sexual desires," said Roberto Fogari, MD, professor of medicine at the University of Pavia, Italy, "but we actually counted the use of sildenafil pills they used which shows the increase." He presented his findings here yesterday at the 17th annual meeting of the American Society of Hypertension.

        Dr. Fogari compared the use of sildenafil among 38 men mild to moderate hypertensives - diastolic blood pressure between 90 and 105 mmHg. They were all aged between 46 and 65 years and able to have an erection only with sildenafil. Study participants were given either 160 mg of valsartan or 20 mg of lisinopril daily in a double-blind crossover manner. The patients were on each antihypertensive medication for 16-week periods.

        "These were men who could only achieve an erection with sildenafil. We assume that because they were increasing their use of sildenafil that their sexual desire increased," he said. Dr. Fogari said the researchers only accumulated information on the number of tablets used-not on the number of intercourse attempts.

        The men who were receiving valsartan began to increase use of sildenafil from a baseline of about 2.5 pills a week after about eight weeks of therapy. By the end of the 16 weeks of treatment they were using 5.5 pills a week. However, he said, when the patients were on lisinopril there was no increase in use of the sildenafil.

        The patients were given four weeks of placebo to measure the antihypertensive effect of the drugs. At baseline before the lisinopril administration, patients had an average blood pressure of 161/100 mmHg. After treatment with lisinopril their blood pressure had fallen to 142/87 mmHg.

        Following another four weeks of placebo, again to assess baseline blood pressure, Dr. Fogari reported that blood pressure fell from 160/101 mmHg to 141/87 mmHg while on valsartan treatment.

        "Because the use of sildenafil significantly increased with the use of valsartan, it suggests that angiotensin II antagonism induces an increase in sexual desire in impotent hypertensive men," Dr. Fogari said.

        "It could be related to the reactive stimulation of angiotensin cascade due to AT1 receptors blockade."

        The study was supported by University of Pavia.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send